The PNPLA3 rs738409 polymorphism is the most abundant genetic risk factor associated with progression of metabolic dysfunction-associated steatotic liver disease (MASLD) to steatohepatitis (MASH) and fibrosis. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.